Getinge has announced the U.S. Food and Drug Administration’s (FDA) 510(k) clearance of the Vasoview Hemopro 3, the latest addition to the medtech company’s endoscopic vessel harvesting (EVH) solutions.
March 12, 2024
Getinge Announces US FDA 510(k) Clearance for Vasoview Hemopro 3 Endoscopic Vessel Harvesting (EVH) solution
March 12, 2024 — Getinge has announced the U.S. Food and Drug Administration’s (FDA) 510(k) clearance of the Vasoview…
Read More
The U.S. Food and Drug Administration (FDA) announced that Abbott is recalling its HeartMate Touch System (version 1.0.32) for risk of unexpected pump stop or start. Issues may occur if the HeartMate Touch System is disconnected from a patient’s HeartMate Controller while a “pump stop” command is running. People who have the implantable HeartMate 3 Left Ventricular Assist Device may be affected.
March 12, 2024
FDA Announces Abbott Recall of HeartMate Touch Communication System for Unintentional Pump Start and Stop
March 12, 2024 — The U.S. Food and Drug Administration (FDA) announced that Abbott is recalling its HeartMate Touch…
Read More
VahatiCor, Inc., a med tech company dedicated to helping patients with persistent ischemic heart disease, has announced the treatment of the first patient with the A-FLUX Reducer System, a treatment for patients with angina or chest pain.
March 11, 2024
VahatiCor, Inc. Announces Treatment of First Patient with the A-FLUX Reducer System Innovation for Patients Suffering from Angina Due to Persistent Ischemic Heart Disease
March 11, 2024 — VahatiCor, Inc., a med tech company dedicated to helping patients with persistent ischemic heart…
Read More
Georgia Tech-led effort to improve support device options for end-stage heart failure
March 08, 2024
The Texas Heart Institute Collaborates on Multi-institutional DOD Grant to Develop Novel Left Ventricular Assist Device
March 8, 2024 —  The Texas Heart Institute, Georgia Institute of Technology (Georgia Tech), North Carolina State…
Read More
Silk Road Medical, Inc., a company focused on reducing the risk of stroke and its devastating impact, today announced that it has launched its Tapered ENROUTE Transcarotid Stent System to hospitals in the United States
March 08, 2024
Silk Road Medical Expands TCAR Portfolio with Launch of Tapered ENROUTE Transcarotid Stent System
March 8, 2024 — Silk Road Medical, Inc., a company focused on reducing the risk of stroke and its devastating impact,…
Read More
The approval is based on the results of SELECT, the largest cardiovascular outcomes trial ever completed for people with obesity and known heart disease
March 08, 2024
FDA Approves Wegovy for Cardiovascular Risk Reduction in Adults with Known Heart Disease and Overweight or Obesity
March 8, 2024 — Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has approved an…
Read More
Cinematic Reality app enables interaction with realistic renderings of human anatomy
March 07, 2024
Siemens Healthineers Launches Cinematic Reality App for Apple Vision Pro
March 7, 2024 — Siemens Healthineers has launched an app designed for Apple Vision Pro that enables users such as…
Read More
The company will showcase AI-enabled innovations and digital solutions that enhance clinical decision making and provide personalized patient care
March 07, 2024
GE HealthCare to Spotlight Industry-Leading AI-Enabled Portfolio and Digital Solutions at HIMSS 2024
March 7, 2024 — GE HealthCare will showcase its industry-leading portfolio of artificial intelligence (AI)-enabled…
Read More
CardiAMP cell therapy-treated patients had 37% relative risk reduction in heart death equivalent (death, heart transplant, left ventricular assist device implantation) and 9% relative risk reduction in non-fatal major adverse cardiac and cerebrovascular events
March 07, 2024
Biocardia Reports Positive Interim Results from Phase III Cardiamp Cell Therapy Heart Failure Trial, with Compelling Data in Subgroup with Elevated NTproBNP Biomarker for Heart Failure
March 7, 2024 — BioCardia, Inc. , a biotechnology company focused on advancing late-stage cell therapy interventions…
Read More
The American College of Cardiology (ACC) has announced its line-up of keynote speakers for the ACC 73rd Annual Scientific Session & Expo, ACC.24, including U.S. Food and Drug Administration Commissioner Robert M. Califf, MD, MACC, among a host of highly-regarded cardiovascular thought leaders and practitioners during the April 6-8 meeting in Atlanta, GA.
March 07, 2024
FDA Commissioner, Host of Cardiovascular Leaders to Offer Keynote Addresses at ACC.24
March 7, 2024 — The American College of Cardiology (ACC) has announced its line-up of keynote speakers for the ACC 73rd…
Read More
Matt Renner, President of North America and Global Startups at Google Cloud, is one of several keynote to be featured during the HIMSS 2024, the Global Conference and Exhibition of the Healthcare Information and Management Systems Society (HIMSS) to be held March 11-15 in Orlando, FL.
March 07, 2024
Google Cloud Leader and High-Profile Keynote Speakers to be Featured at HIMSS24
March 7, 2024 — With just days to go before HIMSS 2024, the Global Conference and Exhibition of the Healthcare…
Read More
Among the many notable trends in CT, one of the fastest growing is the coronary CT angiography market, as witnessed at RSNA23
By Melinda Taschetta-Millane
March 07, 2024
The Evolving Computed Tomography Market
Computed Tomography (CT) continues to be a rapidly evolving technology with many new advancements, as displayed and…
Read More
An AMA letter sent to Secretary Bacerra outlines ongoing concerns of physicians amidst the cybersecurity incident that has impacted Change Healthcare
March 06, 2024
As Cyberattack Jeopardizes Physician Practices, AMA Demands Action
March 6, 2024 — As the cyber-takedown of Change Healthcare has forced medical practices to go without revenue for a…
Read More
Company’s AI-enabled technology for future heart attack risk assessment accepted into FDA’s TAP Pilot and to be validated in landmark TRANSFORM trial
March 06, 2024
Cleerly Receives FDA Breakthrough Device Designation for Heart Disease Risk Staging System
March 6, 2024 — Cleerly, the company on a mission to create a new standard of care to aid in the diagnosis of heart…
Read More
Ensight-AI, a Yale start-up and leader in AI-based cardiovascular diagnostics, announces the receipt of the U.S. Food and Drug Administration’s (FDA) Breakthrough Device Designation for their ECGvision-TTR Technology
March 06, 2024
Ensight-AI Awarded FDA’s Breakthrough Device Designation for Its ECGVision-TTR Technology for Early Detection of ATTR-Cardiomyopathy
March 6, 2024 — Ensight-AI, a Yale start-up and leader in AI-based cardiovascular diagnostics, announces the receipt of…
Read More
Bodyport Inc., a biomarker-guided predictive care company, has presented data showing its FDA-cleared, non-invasive, biomarker-based technology for remote heart failure monitoring detected twice as many heart failure events as compared to the weight-based standard of care.
March 06, 2024
Bodyport Presents Preliminary Analysis of SCALE-HF 1 Study on Remote Heart Failure Monitoring at Technology and Heart Failure Therapeutics (THT) Conference
March 6, 2024 — Bodyport Inc., a biomarker-guided predictive care company focused on heart failure, announced data from…
Read More
Lantheus announced that the U.S. Food and Drug Administration (FDA) has approved DEFINITY (Perflutren Lipid Microsphere) as an ultrasound enhancing agent for use in pediatric patients with suboptimal echocardiograms, including those who have undergone heart transplant, or have Kawasaki disease or a congenital cardiovascular anomaly.
March 06, 2024
Lantheus Announces the FDA Approval of DEFINITY as Ultrasound Enhancing Agent for Use in Certain Pediatric Cardiovascular Patients
March 6, 2024 — Lantheus Holdings, Inc. (Lantheus), a radiopharmaceutical company, has announced that the U.S. Food and…
Read More
Konica Minolta's Exa Platform
By Melinda Taschetta-Millane
March 06, 2024
The Emergence of Cloud-based PACS, and Other Trends
Picture archiving and communication systems (PACS) play a crucial role in modern radiology by providing a digital…
Read More
Hal Wolf, president and CEO of HIMSS
March 06, 2024
One on One ... with Hal Wolf, FHIMSS
Industry trade shows and conferences seem to be making their comeback. The Healthcare Information and Management…
Read More
A look at DAIC's top-viewed content for February 2024
By Melinda Taschetta-Millane
March 05, 2024
A Look at February's Top 10
February was a short but busy month in the diagnostic and interventional cardiology world, with a lot of news being…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now